PuSH - Publication Server of Helmholtz Zentrum München

Hung, R.J.* ; Christiani, D.C.* ; Risch, A.* ; Popanda, O.* ; Haugen, A.* ; Zienolddiny, S.* ; Benhamou, S.* ; Bouchardy, C.* ; Lan, Q.* ; Spitz, M.R.* ; Wichmann, H.-E. ; LeMarchand, L.* ; Vineis, P.* ; Matullo, G.* ; Kiyohara, C.* ; Zhang, Z.F.* ; Pezeshki, B.* ; Harris, C.* ; Mechanic, L.* ; Seow, A.* ; Ng, D.P.* ; Szeszenia-Dabrowska, N.* ; Zaridze, D.* ; Lissowska, J.* ; Rudnai, P.* ; Fabianova, E.* ; Mates, D.* ; Foretova, L.* ; Janout, V.* ; Bencko, V.* ; Caporaso, N.* ; Chen, C.* ; Duell, E.J.* ; Goodman, G.* ; Field, J.K.* ; Houlston, R.S.* ; Hong, Y.C.* ; Landi, M.T.* ; Lazarus, P.* ; Muscat, J.* ; McLaughlin, J.* ; Schwartz, A.G.* ; Shen, H.* ; Stücker, I.* ; Tajima, K.* ; Matsuo, K.* ; Thun, M.* ; Yang, P.* ; Wiencke, J.* ; Andrew, A.S.* ; Monnier, S.* ; Boffetta, P.* ; Brennan, P.*

International Lung Cancer Consortium: Pooled analysis of sequence variants in DNA repair and cell cycle pathways.

Cancer Epidemiol. Biomarkers Prev. 17, 3081-3089 (2008)
DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
BACKGROUND: The International Lung Cancer Consortium was established in 2004. To clarify the role of DNA repair genes in lung cancer susceptibility, we conducted a pooled analysis of genetic variants in DNA repair pathways, whose associations have been investigated by at least 3 individual studies. METHODS: Data from 14 studies were pooled for 18 sequence variants in 12 DNA repair genes, including APEX1, OGG1, XRCC1, XRCC2, XRCC3, ERCC1, XPD, XPF, XPG, XPA, MGMT, and TP53. The total number of subjects included in the analysis for each variant ranged from 2,073 to 13,955 subjects. RESULTS: Four of the variants were found to be weakly associated with lung cancer risk with borderline significance: these were XRCC3 T241M [heterozygote odds ratio (OR), 0.89; 95% confidence interval (95% CI), 0.79-0.99 and homozygote OR, 0.84; 95% CI, 0.71-1.00] based on 3,467 cases and 5,021 controls from 8 studies, XPD K751Q (heterozygote OR, 0.99; 95% CI, 0.89-1.10 and homozygote OR, 1.19; 95% CI, 1.02-1.39) based on 6,463 cases and 6,603 controls from 9 studies, and TP53 R72P (heterozygote OR, 1.14; 95% CI, 1.00-1.29 and homozygote OR, 1.20; 95% CI, 1.02-1.42) based on 3,610 cases and 5,293 controls from 6 studies. OGG1 S326C homozygote was suggested to be associated with lung cancer risk in Caucasians (homozygote OR, 1.34; 95% CI, 1.01-1.79) based on 2,569 cases and 4,178 controls from 4 studies but not in Asians. The other 14 variants did not exhibit main effects on lung cancer risk. DISCUSSION: In addition to data pooling, future priorities of International Lung Cancer Consortium include coordinated genotyping and multistage validation for ongoing genome-wide association studies.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
4.770
1.630
67
93
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords DNA repair; genetic susceptibility; lung cancer
Language english
Publication Year 2008
HGF-reported in Year 2009
ISSN (print) / ISBN 1055-9965
e-ISSN 1538-7755
Quellenangaben Volume: 17, Issue: 11, Pages: 3081-3089 Article Number: , Supplement: ,
Publisher American Association for Cancer Research (AACR)
Reviewing status Peer reviewed
Institute(s) Institute of Epidemiology (EPI)
POF-Topic(s)
30503 - Chronic Diseases of the Lung and Allergies
Research field(s)
Genetics and Epidemiology
PSP Element(s) G-503900-005
G-503900-001
PubMed ID 18990748
Scopus ID 55849112266
Erfassungsdatum 2009-09-10